does glp 1 help with inflammation in the body GLP-1 drugs calm beyond diabetes and weight loss Incretins as Multi–Disease State Treatments

Preliminary pilot studies investigating semaglutide in people with AUD have reported early signals, with some participants experiencing reduced alcohol cravings and fewer heavy drinking days

For example, in the SUSTAIN 5 clinical trial, patients with HbA1c levels of 8.0% or lower had their basal insulin doses reduced by 20% when starting semaglutide therapy to minimize the risk of low blood sugar

TAKEAWAY: At 1 year, the probability of improving by at least one A1c category was 82.7% with sustained GLP-1 RAs vs 67.1% with sustained DPP-4 inhibitors, with an absolute difference of 15.7% (95% CI, 14.8%-16.5%)

53 The dose of 5mg MAR709 was determined to be not tolerated 54 while a wide dose range of tirzepatide from 1mg to 15mg was established